Germline copy number variation of genes involved in chromatin remodelling in families suggestive of Li-Fraumeni syndrome with brain tumours

Aury-Landas, Juliette; Bougeard, Gaëlle; Castel, Hélène; Hernandez-Vargas, Hector; Drouet, Aurélie; Latouche, Jean-Baptiste; Schouft, Marie-Thérèse; Férec, Claude; Leroux, Dominique; Lasset, Christine; Coupier, Isabelle; Caron, Olivier; Herceg, Zdenko; Frebourg, Thierry; Flaman, Jean-Michel
December 2013
European Journal of Human Genetics;Dec2013, Vol. 21 Issue 12, p1369
Academic Journal
Germline alterations of the tumour suppressor TP53 gene are detected approximately in 25% of the families suggestive of Li-Fraumeni syndrome (LFS), characterised by a genetic predisposition to a wide tumour spectrum, including soft-tissue sarcomas, osteosarcomas, premenopausal breast cancers, brain tumours, adrenocortical tumours, plexus choroid tumours, leukaemia and lung cancer. The aim of this study was to determine the contribution of germline copy number variations (CNVs) to LFS in families without detectable TP53 mutation. Using a custom-designed high-resolution array CGH, we evaluated the presence of rare germline CNVs in 64 patients fulfilling the Chompret criteria for LFS, but without any detectable TP53 alteration. In 15 unrelated patients, we detected 20 new CNVs absent in 600 controls. Remarkably, in four patients who had developed each brain tumour, the detected CNV overlap the KDM1A, MTA3, TRRAP or SIRT3 genes encoding p53 partners involved in histone methylation or acetylation. Focused analysis of SIRT3 showed that the CNV encompassing SIRT3 leads to SIRT3 overexpression, and that in vitro SIRT3 overexpression prevents apoptosis, increases G2/M and results in a hypermethylation of numerous genes. This study supports the causal role of germline alterations of genes involved in chromatin remodelling in genetic predisposition to cancer and, in particular, to brain tumours.


Related Articles

  • Efficient Classifier for TP53 Mutants using Feature Relevance Analysis. Poonkuzhali, S.; Ramani, R. Geetha; Kumar, R. Kishore // Proceedings of the International MultiConference of Engineers & ;2012, Vol. 1, p27 

    In medical applications, TP53 have proven to be extremely complex bio markers. Since TP53 germline mutations are the underlying cause of Li-Fraumeni syndrome (LFS), which is a rare autosomal dominant cancer predisposition syndrome therefore classifying TP53 based on family history becomes a...

  • The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations. Silva, Amanda G.; Krepischi, Ana C. V.; Pearson, Peter L.; Hainaut, Pierre; Rosenberg, Carla; Achatz, Maria Isabel // Orphanet Journal of Rare Diseases;2014, Vol. 9 Issue 1, p1 

    Background The Li-Fraumeni syndrome (LFS) is an inherited rare cancer predisposition syndrome characterized by a variety of early-onset tumors. Although germline mutations in the tumor suppressor gene TP53 account for over 50% of the families matching LFS criteria, the lack of TP53 mutation in a...

  • Caspase Activation and Aberrant Cell Growth in a p53+/+ Cell Line from a Li-Fraumeni Syndrome Family. Sherif, Zaki A. // Genetics Research International;3/18/2015, Vol. 2015, p1 

    Wild-type p53 is well known to induce cell cycle arrest and apoptosis to block aberrant cell growth. However, p53’s unique role in apoptosis and cell proliferation in Li-Fraumeni Syndrome (LFS) has not been well elucidated. The aim of this study is to characterize the activity of...

  • Heterogeneity of Li-Fraumeni Syndrome links to unequal gain-of-function effects of p53 mutations. Jie Xu; Jin Qian; Ye Hu; Jilin Wang; Xiaolin Zhou; Haoyan Chen; Jing-Yuan Fang // Scientific Reports;2/28/2014, p1 

    Mutations of p53 cause not only loss of wild-type function but also gain of novel oncogenic functions (GOF). Accumulating evidence suggest that p53 hotspot mutations may confer different types and magnitudes of GOF. Here we add support to the heterogeneity of mutant p53 GOF by showing their...

  • Identification of a novel germ-line mutation in the TP53 gene in a Mexican family with Li-Fraumeni syndrome.  // World Journal of Surgical Oncology;2009, Vol. 7, p97 

    Background: Germ-line mutations of the TP53 gene are known to cause Li-Fraumeni syndrome, an autosomal, dominantly inherited, high-penetrance cancer-predisposition syndrome characterized by the occurrence of a variety of cancers, mainly soft tissue sarcomas, adrenocortical carcinoma, leukemia,...

  • A Pathogenic Mosaic TP53 Mutation in Two Germ Layers Detected by Next Generation Sequencing. Behjati, Sam; Maschietto, Mariana; Williams, Richard D.; Side, Lucy; Hubank, Mike; West, Rebecca; Pearson, Katie; Sebire, Neil; Tarpey, Patrick; Futreal, Andrew; Brooks, Tony; Stratton, Michael R.; Anderson, John // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Background: Li-Fraumeni syndrome is caused by germline TP53 mutations and is clinically characterized by a predisposition to a range of cancers, most commonly sarcoma, brain tumours and leukemia. Pathogenic mosaic TP53 mutations have only rarely been described. Methods and Findings: We describe...

  • Li-Fraumeni Syndrome and p53 in 2015: Celebrating their Silver Anniversary. Malkin, David // Clinical & Investigative Medicine;Feb2016, Vol. 39 Issue 1, pE37 

    In a typical morning in the Cancer Genetics Clinic at The Hospital for Sick Children in Toronto, the following array of patients and families might be seen: a family of three children, all harbouring a mutation of the succinyl dehydrogenase C gene inherited from their father who had had...

  • TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families. Cury, Nathalia M.; Ferraz, Victor E. F.; Silva Jr, Wilson A. // Hereditary Cancer in Clinical Practice;2014, Vol. 12 Issue 1, p1 

    Background: Approximately 5-10% of breast cancers are hereditary. Among hereditary syndromes, Hereditary Breast and Ovarian Cancer Syndrome (HBOC) and Li-Fraumeni Syndrome (LFS) have received the most attention. HBOC is due to mutations in the BRCA1 and BRCA2 genes and is characterized by breast...

  • RECQL4 and p53 potentiate the activity of polymerase γ and maintain the integrity of the human mitochondrial genome. Gupta, Shruti; De, Siddharth; Srivastava, Vivek; Hussain, Mansoor; Kumari, Jyoti; Muniyappa, K.; Sengupta, Sagar // Carcinogenesis;Jan2014, Vol. 35 Issue 1, p34 

    Germline mutations in RECQL4 and p53 lead to cancer predisposition syndromes, Rothmund–Thomson syndrome (RTS) and Li–Fraumeni syndrome (LFS), respectively. RECQL4 is essential for the transport of p53 to the mitochondria under unstressed conditions. Here, we show that both RECQL4...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics